|
This report is being submitted to relay additional information and device evaluation.The following sections are being reported: h6: component code was added: 4755.H6: tyoe of investigation codes were added: 4109, 4111, 4110 and 3331.H6: investigation findings code was added: 213.H6: investigation conclusions code was added: 4310 and 4315.One (1) imp, tsv, 3.7, 13, mtxf, mg,ha (tsvth13) was returned for investigation.Visual evaluation of the as returned product identified no apparent malfunction.Signs of use only.Based on the evaluation, device malfunction has not occurred.Additionally, there is no existing nonconformance / capa / hhe/d / ie / product hold against the reported device that did or could cause or contribute to the reported event.Monthly post market trending review identified no adverse trends or actionable trends for the reported event or device.Zimmer biomet quality management system (qms) has controls in place to ensure the distribution of conforming products.Therefore, based on the available information, the product was within specifications and conforming when it left zimmer biomet.Dhr review for the lot number (1239688) had revealed no deviations nor non-conformances which could have caused or contributed to the reported event.Sterilization record (op#120) was reviewed and verified to have passed all sterilization activities with no issues or nonconformities identified.Complaint history review by lot number (1239688) was performed for similar events using keyword (medical: pain) and no other similar complaint was identified.The reported event could not be recreated due to the nature of the dental device and event (pain) and the complaint is not related to the functional performance of the device.A definitive root cause could not be identified.However, based on the investigation and risk review, the most likely causes for the reported event is implant material rejection; allergies, sensitivity.No further investigation or immediate capa / hhe/d escalation is required, as the complaint investigation did not confirm the product was nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.
|